Future Procurement Opportunity (FPO) - Supply of Bevacizumab

Future Procurement Opportunity (FPO) - Supply of Bevacizumab

Details

RFx ID: 29939939 Tender Name: Future Procurement Opportunity (FPO) - Supply of Bevacizumab

• 51000000 - Drugs and Pharmaceutical Products

Regions:

• New Zealand

Required Pre-qualifications: None Contact: Pharmac Procurement Team procurement@Pharmac.govt.nz Pharmac is planning on issuing a competitive process for the supply of bevacizumab. Bevacizumab is currently funded for recurrent respiratory papillomatosis, ocular neovascularisation, and exudative ocular angiopathy in Health NZ Hospitals. The current eligibility criteria for bevacizumab can be found here . This competitive process may result in additional funded indications and may or may not also result in widened access to the current criteria. The Pharmaceutical Schedule is a list of funded medicines in the community and/or that can be used in Health New Zealand | Te Whatu Ora hospitals. More information on the Schedule can be found here . Funding applications for bevacizumab currently under consideration can be found on the Pharmac Application Tracker here . Links to specific funding proposals under consideration are provided below.

• Bevacizumab used in the treatment of hepatocellular carcinoma:
  • Proposal: P-001618
• Bevacizumab used in the treatment of colorectal cancer:
  • Proposal: P-000055
• Bevacizumab used in the treatment of glioma:
  • Proposal: P-000265
  • Proposal: P-000740
• Bevacizumab used in the treatment of ovarian cancer:
  • Proposal: P-001366
  • Proposal: P-001803
• Bevacizumab used in the treatment of cervical cancer:
  • Proposal: P-000311

The indicative release date that the buying agency expects a realised procurement process to commence will be presented to suppliers by calendar quarter. Please note that the FPO will close on this date. Initial Development (Concept Phase) - the buying agency is investigating options to procure in the future (high-level information expected around the activity). Budget may or may not be available. The indicative combined value of any realised tenders that may arise from this FPO is intended to set an expectation of the scope of work that is required. An individual agency purchasing on its own behalf. #J-18808-Ljbffr